Women Overcoming and Managing Adversity Now (WOMAN) Study (WOMAN)

March 28, 2011 updated by: UConn Health
The goal of the study is to evaluate the efficacy of a two therapeutic models designed to enhance women's skills for managing reactive emotions in their current lives as well as to educate them about how using these skills can enhance their personal effectiveness and help them to gain control of post-traumatic stress reactions. The interventions adaptations of a manualized psychotherapy that has shown promise with adults with complex Posttraumatic Stress Disorder (PTSD) (Trauma Affect Regulation: Guide for Education and Therapy; TARGET) compared to a supportive group therapy (SGT) that has been found to have modest benefits with women survivors of childhood abuse (Wallis, 2002).

Study Overview

Status

Completed

Detailed Description

In a randomized treatment design, we will compare offenders receiving skills-based intervention (TARGET) and those receiving a similar amount of supportive intervention (SGT). We will assess the efficacy of treatment by determining if those receiving the TARGET skills training show an improvement in functionality, as compared to those receiving only supportive intervention. We will measure this by analyzing PTSD symptoms, psychological distress, psychosocial functioning, and social/legal adjustment and services using structured interviews, self-report questionnaires and qualitative questions. Questionnaires are listed below in the outcome measure's section. We will collect follow-up data on program participants who successfully finish the program at York. For those offenders who discharge into the community directly from York, we will collect follow-up data on program participants through CDOC Parole or Probation records. Statistically we anticipate a medium effect size difference between the treatment conditions.

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • Niantic, Connecticut, United States, 06357
        • York Correctional Institution

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Incarcerated, release not expected within 6 months
  • Probable PTSD on PC-PTSD screen and PTSD by CAPS interview

Exclusion Criteria

  • Clinically significant psychopathy (PCL-SV severe range)
  • Unable to comprehend study materials (Mini-Mental Status Exam Orientation, Attention, and Recall sections total score <15).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TARGET
12-session affect regulation therapy for PTSD
12-session group therapy twice weekly 6 weeks
Active Comparator: SGT
12 session supportive group therapy
12 sessions supportive group therapy twice weekly 6 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PTSD
Time Frame: Post-therapy (within 2 weeks)
PTSD symptom severity, Clinician Administered PTSD Scale
Post-therapy (within 2 weeks)
PTSD
Time Frame: 3-4 Month Post-therapy Follow-up
PTSD symptom severity, Clinician Administered PTSD Scale
3-4 Month Post-therapy Follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emotion Regulation
Time Frame: Post-therapy (within 2 weeks)
Negative Mood Regulation Scale
Post-therapy (within 2 weeks)
Trauma-related symptoms
Time Frame: Post-therapy (within 2 weeks)
Trauma Symptom Inventory (TSI; Briere, 1995). The TSI is a reliable and validated 100-item measure that generates composite scores for trauma (PTSD symptoms), self (self-regulation problems), and dysphoria (depression, anxiety, anger symptoms).
Post-therapy (within 2 weeks)
Mental health symptoms, well-being, and self-harm
Time Frame: Post-therapy (within 2 weeks)
CORE-OM is a 34-item self-report measure reliably and validly assessing current psychiatric symptom severity, risk of harm to self or others, social functioning, and subjective well being
Post-therapy (within 2 weeks)
Emotion Regulation
Time Frame: 3-4 Month Post-therapy Follow-up
Negative Mood Regulation Scale
3-4 Month Post-therapy Follow-up
Trauma-related Symptoms
Time Frame: 3-4 Month Post-therapy Follow-up
Trauma Symptom Inventory
3-4 Month Post-therapy Follow-up
Mental health symptoms, well-being, and self-harm
Time Frame: 3-4 Month Post-therapy Follow-up
CORE-OM 34-item questionnaire
3-4 Month Post-therapy Follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Julian D Ford, Ph.D., Uconn Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2009

Primary Completion (Actual)

November 1, 2010

Study Completion (Actual)

November 1, 2010

Study Registration Dates

First Submitted

September 23, 2010

First Submitted That Met QC Criteria

March 28, 2011

First Posted (Estimate)

March 29, 2011

Study Record Updates

Last Update Posted (Estimate)

March 29, 2011

Last Update Submitted That Met QC Criteria

March 28, 2011

Last Verified

March 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • 09009-2
  • 2009-DD-BX-0003 (Other Grant/Funding Number: Department of Justice)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD

Clinical Trials on TARGET

3
Subscribe